Saturday 17 October 2026
Export CNMD’s income statement to Excel — free account
CONMED Corporation
CNMD Healthcare Medical Devices
CONMED Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 5.18% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 11.6%, free cash flow grew 46.0% and total debt fell 5.40%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.
46.72
0.42
−0.89%
Follow CNMD
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
84.98 | 25.43 | 43.97 | 109.64 | 339.39 | 66.24 | 0.00 | 52.19 | 15.95 | 26.89 |
Piotroski F-Score |
4 | 6 | 6 | 4 | 5 | 8 | 2 | 7 | 8 | 5 |
P/S ratio |
1.61 | 1.78 | 2.10 | 3.32 | 3.71 | 4.09 | 2.58 | 2.71 | 1.62 | 0.92 |
Altman Z-Score |
2.28 | 2.51 | 2.99 | 2.98 | 2.94 | 3.88 | 1.99 | 2.52 | 2.32 | 1.86 |
Altman Z″-Score (non-manufacturers) |
3.07 | 3.20 | 3.46 | 2.64 | 2.59 | 3.15 | 2.11 | 2.46 | 3.16 | 2.97 |
P/FCF ratio |
48.90 | 26.82 | 31.02 | 42.20 | 62.14 | 42.66 | 232.82 | 31.77 | 13.72 | 8.35 |
Beneish M-Score |
(2.53) | (2.42) | (2.51) | (2.67) | (2.68) | (2.57) | (2.69) | (2.37) | (2.55) | (2.70) |
P/Operating CF |
89.73 | 67.94 | 73.08 | 77.49 | 158.90 | 122.36 | (232.46) | 59.89 | 48.71 | 27.19 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 63 |
P/B ratio |
2.12 | 2.24 | 2.73 | 4.46 | 4.51 | 5.26 | 3.62 | 4.05 | 2.19 | 1.22 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
2.23 | 2.35 | 2.61 | 4.09 | 4.55 | 4.75 | 3.56 | 3.48 | 2.29 | 1.49 |
EV/EBITDA |
18.28 | 17.71 | 16.86 | 23.96 | 29.74 | 24.68 | 25.76 | 21.79 | 10.77 | 11.25 |
EV/Operating CF |
42.62 | 28.49 | 30.05 | 41.11 | 60.86 | 42.93 | 111.55 | 34.52 | 17.92 | 12.03 |
EV/FCF |
67.64 | 35.43 | 38.57 | 52.09 | 76.23 | 49.51 | 321.41 | 40.70 | 19.45 | 13.61 |
Quick Ratio |
1.54 | 1.33 | 1.24 | 1.14 | 1.08 | 1.04 | 0.74 | 0.86 | 0.94 | 0.92 |
Current Ratio |
2.90 | 2.38 | 2.33 | 2.11 | 2.19 | 2.34 | 1.96 | 1.98 | 2.30 | 2.14 |
Net Debt/EBITDA |
5.07 | 4.30 | 3.30 | 4.55 | 5.50 | 3.41 | 7.10 | 4.78 | 3.17 | 4.35 |
Debt/Assets |
37.51% | 35.82% | 33.37% | 43.31% | 43.02% | 38.77% | 45.91% | 42.34% | 39.28% | 35.90% |
Debt/Equity |
0.86 | 0.77 | 0.69 | 1.08 | 1.06 | 0.87 | 1.41 | 1.17 | 0.94 | 0.81 |
Asset Turnover |
0.63 | 0.59 | 0.63 | 0.61 | 0.49 | 0.57 | 0.51 | 0.54 | 0.57 | 0.59 |
Operating CF/Net income |
2.72 | 1.18 | 1.83 | 3.32 | 6.78 | 1.79 | (0.41) | 1.94 | 1.26 | 3.63 |
Capex/Depreciation |
(0.27) | (0.22) | (0.27) | (0.24) | (0.15) | (0.18) | (0.29) | (0.24) | (0.17) | (0.25) |
Interest Coverage |
2.45 | 2.58 | 3.45 | 1.85 | 1.04 | 3.09 | 2.42 | 3.03 | 5.37 | 3.30 |
| 2.52% | 9.16% | 6.32% | 4.17% | 1.34% | 8.37% | (10.53%) | 8.16% | 14.74% | 4.72% | |
| 1.21% | 4.13% | 3.00% | 1.82% | 0.54% | 3.56% | (3.97%) | 2.80% | 5.75% | 2.03% | |
ROIC |
2.24% | 2.70% | 4.05% | 3.40% | 2.00% | 4.73% | 2.47% | 4.23% | 6.79% | 3.51% |
Return on Tangible Assets |
4.33% | 17.18% | 12.51% | 8.72% | 2.82% | 16.80% | (20.13%) | 15.14% | 27.72% | 9.99% |
Average Days of Receivables |
70.87 | 76.56 | 77.09 | 72.27 | 74.97 | 66.41 | 66.80 | 71.04 | 66.39 | 65.80 |
Research and Development Expense of Revenue |
4.22% | 4.06% | 4.91% | 4.76% | 4.69% | 4.31% | 4.51% | 4.23% | 4.16% | 4.07% |
Selling, General and Administrative Expense of Revenue |
44.32% | 44.17% | 41.37% | 41.90% | 43.34% | 41.04% | 43.43% | 40.41% | 36.59% | 43.06% |
Intangible Assets out of Total Assets |
0.61 | 0.60 | 0.59 | 0.65 | 0.64 | 0.62 | 0.65 | 0.63 | 0.62 | 0.60 |
Share Based Compensation of Revenue |
1.10% | 1.06% | 1.17% | 1.23% | 1.52% | 1.62% | 2.08% | 1.95% | 1.96% | 2.06% |
Graham Net Nets |
(0.34) | (0.26) | (0.18) | (0.21) | (0.20) | (0.13) | (0.36) | (0.25) | (0.33) | (0.49) |
Graham Number |
15.63 | 31.81 | 27.82 | 23.99 | 13.57 | 36.01 | 0.00 | 35.94 | 54.89 | 33.63 |
Earnings Yield |
1.18% | 3.93% | 2.27% | 0.91% | 0.29% | 1.51% | (3.08%) | 1.92% | 6.27% | 3.72% |
Free Cash Flow Yield |
2.05% | 3.73% | 3.22% | 2.37% | 1.61% | 2.34% | 0.43% | 3.15% | 7.29% | 11.97% |
Revenue per Share |
27.46 | 28.50 | 30.57 | 33.72 | 30.18 | 34.66 | 34.80 | 40.59 | 42.37 | 44.29 |
Operating CF per Share |
1.43 | 2.35 | 2.66 | 3.36 | 2.26 | 3.83 | 1.11 | 4.09 | 5.41 | 5.50 |
Capex per Share |
(0.53) | (0.46) | (0.59) | (0.71) | (0.46) | (0.51) | (0.73) | (0.62) | (0.42) | (0.64) |
Free Cash Flow per Share |
0.90 | 1.89 | 2.07 | 2.65 | 1.80 | 3.32 | 0.39 | 3.47 | 4.99 | 4.86 |
Cash per Share |
0.99 | 1.17 | 0.62 | 0.91 | 0.96 | 0.71 | 0.96 | 0.79 | 0.79 | 1.32 |
Shareholders Equity per Share |
20.88 | 22.60 | 23.55 | 25.08 | 24.81 | 26.93 | 24.82 | 27.20 | 31.21 | 33.29 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
20.88 | 22.60 | 23.55 | 25.08 | 24.81 | 26.93 | 24.82 | 27.20 | 31.21 | 33.29 |
Free Cash Flow |
25.13 | 52.72 | 58.19 | 75.07 | 51.52 | 96.90 | 11.58 | 106.32 | 153.88 | 150.88 |
Working Capital |
216.56 | 206.78 | 213.41 | 209.28 | 226.45 | 263.48 | 284.67 | 304.92 | 361.88 | 357.82 |
Capital Expenditures |
(14.75) | (12.84) | (16.51) | (20.07) | (13.01) | (14.87) | (21.78) | (19.03) | (13.08) | (19.81) |
Net Current Asset Value |
(417.89) | (369.75) | (332.52) | (667.26) | (625.98) | (520.46) | (970.82) | (850.15) | (703.56) | (619.79) |
EV/EBIT |
45.11 | 39.80 | 31.48 | 49.43 | 85.36 | 43.73 | 53.13 | 35.88 | 14.94 | 20.02 |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 |
Price to Operating Income |
32.61 | 30.13 | 25.32 | 40.04 | 69.57 | 37.68 | 38.49 | 28.00 | 10.54 | 12.28 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.45 | 0.50 | 0.55 | 0.71 | 0.77 | 0.78 | 0.64 | 0.65 | 0.67 | 0.71 |
Cash ROIC |
2.27% | 4.58% | 5.12% | 4.99% | 3.46% | 6.50% | 0.63% | 5.80% | 8.13% | 7.90% |
Accounts Receivable Turnover |
5.41 | 5.05 | 4.93 | 5.15 | 4.71 | 5.60 | 5.57 | 5.74 | 5.45 | 5.66 |
Accounts Payable Turnover |
9.30 | 8.73 | 8.17 | 7.86 | 7.36 | 7.94 | 7.21 | 7.04 | 6.03 | 6.37 |
Inventory Turnover |
2.64 | 2.64 | 2.64 | 2.70 | 2.24 | 2.08 | 1.68 | 1.75 | 1.73 | 1.78 |
Average Days of Payables |
42.80 | 42.00 | 50.00 | 47.47 | 48.38 | 47.99 | 56.49 | 56.64 | 65.02 | 54.76 |
Days of Inventory on Hand |
139.62 | 141.30 | 144.49 | 139.61 | 176.86 | 191.03 | 255.78 | 204.38 | 220.48 | 207.89 |
Average Receivables |
141.05 | 157.64 | 174.29 | 185.32 | 183.12 | 180.52 | 187.61 | 216.81 | 240.01 | 242.78 |
Average Payables |
38.18 | 41.85 | 47.77 | 54.73 | 54.64 | 55.75 | 65.80 | 80.81 | 95.24 | 97.95 |
Average Inventory |
134.62 | 138.65 | 148.02 | 159.61 | 179.74 | 213.26 | 281.98 | 325.32 | 332.52 | 351.13 |
Average Assets |
1,215.34 | 1,343.47 | 1,363.55 | 1,572.12 | 1,763.38 | 1,758.85 | 2,031.80 | 2,298.81 | 2,303.13 | 2,316.00 |
Average Common Equity |
582.82 | 606.00 | 646.85 | 686.37 | 709.75 | 747.24 | 765.49 | 789.88 | 898.45 | 997.89 |
Columns are period end dates